Age-specific mortality and immunity patterns of SARS-CoV-2
Tóm tắt
Từ khóa
Tài liệu tham khảo
Pastor-Barriuso, R. et al. Infection fatality risk for SARS-CoV-2: a nationwide seroepidemiological study in the non-institutionalized population of Spain. Preprint at http://doi.org/10.1101/2020.08.06.20169722 (2020).
Verity, R. et al. Estimates of the severity of coronavirus disease 2019: a model-based analysis. Lancet Infect. Dis. 20, 669–677 (2020).
Comas-Herrera, A. et al. Mortality associated with COVID-19 Outbreaks in Care Homes: Early International Evidence. https://ltccovid.org/2020/04/12/mortality-associated-with-covid-19-outbreaks-in-care-homes-early-international-evidence/ (2020).
Guan, W.-J. et al. Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med. 382, 1708–1720 (2020).
Clark, A. et al. Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study. Lancet Glob. Health 8, e1003–e1017 (2020).
Pollán, M. et al. Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study. Lancet 396, 535–544 (2020).
Stringhini, S. et al. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study. Lancet 396, 313–319 (2020).
Rosenberg, E. S. et al. Cumulative incidence and diagnosis of SARS-CoV-2 infection in New York. Ann. Epidemiol. 48, 23–29 (2020).
Herzog, S. et al. Seroprevalence of IgG antibodies against SARS coronavirus 2 in Belgium — a prospective cross-sectional study of residual samples. Preprint at https://doi.org/10.1101/2020.06.08.20125179 (2020).
Takahashi, S., Greenhouse, B. & Rodríguez-Barraquer, I. Are seroprevalence estimates for severe acute respiratory syndrome coronavirus 2 biased? J. Infect. Dis. 222, 1772–1775 (2020).
Prem, K., Cook, A. R. & Jit, M. Projecting social contact matrices in 152 countries using contact surveys and demographic data. PLOS Comput. Biol. 13, e1005697 (2017).
Jin, J.-M. et al. Gender differences in patients with COVID-19: focus on severity and mortality. Front. Public Health 8, 152 (2020).
Huang, A. T. et al. A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity. Nat. Commun. 11, 4704 (2020).
Braun, J. et al. SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19. Nature 587, 270–274 (2020).
Buss, L. F. et al. COVID-19 herd immunity in the Brazilian Amazon. Preprint at https://doi.org/10.1101/2020.09.16.20194787 (2020).
Antonio, C. A. A. et al. Seroprevalencia de Anticuerpos anti SARS-CoV-2 en la Ciudad de Iquitos, Loreto, Perú. https://docs.google.com/document/d/1K-aKyFmxztdfNJOtXuSH1uGcBeaZA7LH/edit (2020).
Del Brutto, O. H. et al. SARS-CoV-2 in rural Latin America. A population-based study in coastal Ecuador. Clin. Infect. Dis. ciaa1055 (2020).
Flaxman, S. et al. Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe. Nature 584, 257–261 (2020).
Abrams, S. et al. Modeling the early phase of the Belgian COVID-19 epidemic using a stochastic compartmental model and studying its implied future trajectories. Preprint at https://doi.org/10.1101/2020.06.29.20142851 (2020).
Fontanet, A. & Cauchemez, S. COVID-19 herd immunity: where are we? Nat. Rev. Immunol. 20, 583–584 (2020).
Molenberghs, G. et al. Belgian COVID-19 mortality, excess deaths, number of deaths per million, and infection fatality rates (8 March - 9 May 2020). Preprint at https://doi.org/10.1101/2020.06.20.20136234 (2020).
Soveri, H. et al. Why, in almost all countries, was residential care for older people so badly affected by COVID-19? http://www.ose.be/files/publication/OSEPaperSeries/Declercq_Et_Al_2020_OpinionPaper23.pdf (European Social Observatory, 2020).
Hardy, O. J. et al. A world apart: levels and factors of excess mortality due to COVID-19 in care homes. The case of Wallonia - Belgium. Preprint at https://doi.org/10.1101/2020.08.29.20183210 (2020).
Aron, J., Giattino, C., Muellbauer, J. & Ritchie, H. A pandemic primer on excess mortality statistics and their comparability across countries. Our World in Data https://ourworldindata.org/covid-excess-mortality (2020).
Dong, E., Du, H. & Gardner, L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect. Dis. 20, 533–534 (2020).
De Wulf, M. Population Pyramids of the World from 1950 to 2100. https://www.populationpyramid.net/world/2019/ (2016).
UN Department of Economic and Social Affairs. World Population Prospects 2019. https://population.un.org/wpp/ (UN, 2019).
Caul, S. Deaths registered weekly in England and Wales, provisional. https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/datasets/weeklyprovisionalfiguresondeathsregisteredinenglandandwales (UK Office for National Statistics, 2020).
Wu, J. T. et al. Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China. Nat. Med. 26, 506–510 (2020).
Backer, J. A., Klinkenberg, D. & Wallinga, J. Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20–28 January 2020. Euro Surveill. 25, 2000062 (2020).
Lou, B. et al. Serology characteristics of SARS-CoV-2 infection after exposure and post-symptom onset. Eur. Respir. J. 56, 2000763 (2020).
Wu, J. T. et al. The infection attack rate and severity of 2009 pandemic H1N1 influenza in Hong Kong. Clin. Infect. Dis. 51, 1184–1191 (2010).
Stan Development Team. RStan: the R interface to Stan. R package version 2 https://mc-stan.org/users/interfaces/rstan (2016).